within Pharmacolibrary.Drugs.ATC.R;

model R01AA14
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.021666666666666667,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R01AA14</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Epinephrine (also known as adrenaline) is a naturally occurring catecholamine hormone and neurotransmitter used primarily in emergency medicine. It is indicated for the treatment of severe allergic reactions (anaphylaxis), cardiac arrest, and as a vasoconstrictor in shock. It is approved and widely used today in various clinical settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult healthy individuals. No direct publication was found for intranasal/ATC R01AA14-specific administration; values are extrapolated from general human PK and alternative routes (intramuscular/intravenous) as reference.</p><h4>References</h4><ol><li><p>Casale, TB, et al., &amp; Tanimoto, S (2023). Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection. <i>The Journal of allergy and clinical immunology</i> 152(6) 1587–1596. DOI:<a href=&quot;https://doi.org/10.1016/j.jaci.2023.08.007&quot;>10.1016/j.jaci.2023.08.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37604314/&quot;>https://pubmed.ncbi.nlm.nih.gov/37604314</a></p></li><li><p>Tal, Y, et al., &amp; Caraco, Y (2023). Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis. <i>The journal of allergy and clinical immunology. In practice</i> 11(10) 3047–3054. DOI:<a href=&quot;https://doi.org/10.1016/j.jaip.2023.06.044&quot;>10.1016/j.jaip.2023.06.044</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37394178/&quot;>https://pubmed.ncbi.nlm.nih.gov/37394178</a></p></li><li><p>Tuttle, R, et al., &amp; Dretchen, KL (2020). Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model. <i>Respiratory research</i> 21(1) 78–None. DOI:<a href=&quot;https://doi.org/10.1186/s12931-020-01343-x&quot;>10.1186/s12931-020-01343-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32245384/&quot;>https://pubmed.ncbi.nlm.nih.gov/32245384</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R01AA14;
